Corcept Therapeutics Incorporated Financial Flexibility Index
Corcept Therapeutics Incorporated financial flexibility index. Corcept Therapeutics Incorporated (CORT) has a Financial Flexibility Index of -0.09x as of March 2026. Free cash flow of $-16.57 Million (operating CF $-16.77 Million minus capex $201.00K) represents 0% of total liabilities ($176.89 Million). See free cash flow generation of Corcept Therapeutics Incorporated to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Corcept Therapeutics Incorporated (2003–2025)
Financial flexibility index of Corcept Therapeutics Incorporated from 2003 to 2025. Historical Financial Flexibility Index trend for Corcept Therapeutics Incorporated across 23 annual periods. Check CORT cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Corcept Therapeutics Incorporated Financial Flexibility Index by Year (2003–2025)
Corcept Therapeutics Incorporated financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Corcept Therapeutics Incorporated. For the full cash flow conversion analysis, see CORT cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.75x | $142.21 Million | $142.00 Million | $188.85 Million | ▼ -39.5% |
| 2024 | 1.24x | $200.24 Million | $198.07 Million | $160.96 Million | ▲ +12.3% |
| 2023 | 1.11x | $127.18 Million | $127.04 Million | $114.81 Million | ▼ -25.1% |
| 2022 | 1.48x | $120.74 Million | $120.32 Million | $81.59 Million | ▼ -57.9% |
| 2021 | 3.51x | $168.36 Million | $167.89 Million | $47.95 Million | ▲ +10.9% |
| 2020 | 3.17x | $153.21 Million | $151.97 Million | $48.39 Million | ▼ -5.1% |
| 2019 | 3.34x | $137.21 Million | $136.12 Million | $41.13 Million | ▲ +3.0% |
| 2018 | 3.24x | $115.96 Million | $115.67 Million | $35.81 Million | ▲ +56.1% |
| 2017 | 2.07x | $61.35 Million | $60.94 Million | $29.57 Million | ▲ +205.6% |
| 2016 | 0.68x | $18.59 Million | $18.39 Million | $27.37 Million | ▲ +621.4% |
| 2015 | 0.09x | $3.15 Million | $3.13 Million | $33.44 Million | ▲ +113.2% |
| 2014 | -0.72x | $-27.20 Million | $-27.38 Million | $38.02 Million | ▲ +18.5% |
| 2013 | -0.88x | $-36.93 Million | $-37.06 Million | $42.06 Million | ▲ +8.5% |
| 2012 | -0.96x | $-35.87 Million | $-36.02 Million | $37.39 Million | ▲ +82.4% |
| 2011 | -5.45x | $-27.38 Million | $-27.40 Million | $5.03 Million | ▲ +5.7% |
| 2010 | -5.77x | $-22.29 Million | $-22.29 Million | $3.86 Million | ▲ +22.2% |
| 2009 | -7.42x | $-17.96 Million | $-17.97 Million | $2.42 Million | ▼ -16.0% |
| 2008 | -6.40x | $-18.36 Million | $-18.36 Million | $2.87 Million | ▼ -75.7% |
| 2007 | -3.64x | $-10.96 Million | $-10.96 Million | $3.01 Million | ▲ +41.1% |
| 2006 | -6.19x | $-21.92 Million | $-23.24 Million | $3.54 Million | ▼ -355.6% |
| 2005 | 2.42x | $8.63 Million | $-17.23 Million | $3.56 Million | ▼ -95.1% |
| 2004 | 49.44x | $90.18 Million | $-13.72 Million | $1.82 Million | ▲ +860.0% |
| 2003 | -6.51x | $-10.00 Million | $-10.00 Million | $1.54 Million | — |